Clinical trials
Completed Phase 2 Arthritis, Rheumatoid trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
310 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 4 |
| 2001 | 5 |
| 2002 | 11 |
| 2003 | 8 |
| 2004 | 12 |
| 2005 | 20 |
| 2006 | 20 |
| 2007 | 19 |
| 2008 | 21 |
| 2009 | 18 |
| 2010 | 19 |
| 2011 | 20 |
| 2012 | 21 |
| 2013 | 14 |
| 2014 | 10 |
| 2015 | 11 |
| 2016 | 15 |
| 2017 | 10 |
| 2018 | 6 |
| 2019 | 9 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 9 |
| 2023 | 6 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 310 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 21 |
| GlaxoSmithKline | 12 |
| Amgen | 10 |
| Bristol-Myers Squibb | 9 |
| Eli Lilly and Company | 9 |
| Lakefront Biotherapeutics NV | 8 |
| AbbVie | 7 |
| Genentech, Inc. | 6 |
| Hoffmann-La Roche | 6 |
| Janssen Research & Development, LLC | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arthritis, Rheumatoid | 310 |
| Arthritis | 23 |
| Autoimmune Diseases | 8 |
| Inflammation | 7 |
| Joint Diseases | 7 |
| Arthritis, Psoriatic | 6 |
| Musculoskeletal Diseases | 5 |
| Lupus Erythematosus, Systemic | 4 |
| Osteoarthritis | 4 |
| Rheumatic Diseases | 4 |
Trials
Showing 1 to 25 of 310. Each trial links to its page on Pharma Observatory.
210 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.